ES2039237T3
(es)
*
|
1986-04-24 |
1993-09-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Procedimiento para preparar nuevos compuestos de acido difosfonico.
|
IL84493A
(en)
*
|
1986-11-21 |
1993-01-14 |
Ciba Geigy Ag |
Aromatically substituted azacycloalkylalk - anediphosphonic acids, their preparation and pharmaceutical compositions containing them
|
DE3640938A1
(de)
*
|
1986-11-29 |
1988-06-01 |
Boehringer Mannheim Gmbh |
Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindung enthaltende arzneimittel
|
US5110807A
(en)
*
|
1988-12-01 |
1992-05-05 |
Ciba-Geigy Corporation |
Araliphatylaminoalkanediphosphonic acids
|
US5190930A
(en)
*
|
1987-12-11 |
1993-03-02 |
Ciba-Geigy Corporation |
Araliphatylaminoalkanediphosphonic acids
|
US7452359B1
(en)
*
|
1988-06-13 |
2008-11-18 |
Warsaw Orthopedic, Inc. |
Apparatus for inserting spinal implants
|
WO1990009179A1
(en)
*
|
1989-02-16 |
1990-08-23 |
University Of Georgia Research Foundation, Inc. |
Treatment of tibial dyschondroplasia
|
US5316770A
(en)
*
|
1989-02-16 |
1994-05-31 |
University Of Georgia Research Foundation, Inc. |
Vitamin D derivative feed compositions and methods of use
|
US5366736A
(en)
*
|
1989-02-16 |
1994-11-22 |
University Of Georgia Research Foundation, Inc. |
Vitamin D derivative feed compositions and methods of use
|
MX21452A
(es)
*
|
1989-07-07 |
1994-01-31 |
Ciba Geigy Ag |
Preparaciones farmaceuticas que se administran en forma topica.
|
US5139786A
(en)
*
|
1989-07-07 |
1992-08-18 |
Ciba-Geigy Corporation |
Topical formulations
|
US5356887A
(en)
*
|
1990-01-31 |
1994-10-18 |
Merck & Co., Inc. |
Pharmaceutical compositions containing insoluble calcium salts of amino-hydroxybutylidene bisphoshonic acids
|
US5204334A
(en)
*
|
1990-10-18 |
1993-04-20 |
Ciba-Geigy Corporation |
Benzoheterocyclylalkylaminoalkanediphosphonic acids, compositions thereof, and use thereof in the treatment of calcium metabolism disorders
|
HU215124B
(hu)
|
1991-02-26 |
1998-09-28 |
Norwich Eaton Pharmaceuticals, Inc. |
Eljárás csontritkulás (osteoporosis) kezelésére szolgáló ösztrogént és difoszfonátot tartalmazó, szinergetikus hatású gyógyszerkészítmények előállítására
|
ATE147396T1
(de)
*
|
1991-08-27 |
1997-01-15 |
Ciba Geigy Ag |
N-substituierte aminomethandiphosphonsäuren
|
WO1993011786A1
(en)
*
|
1991-12-17 |
1993-06-24 |
Procter & Gamble Pharmaceuticals, Inc. |
Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone
|
US5382658A
(en)
*
|
1992-04-03 |
1995-01-17 |
Allelix Biopharmaceuticals Inc. |
Stability-enhanced variants of parathyroid hormone
|
WO1994000129A1
(en)
*
|
1992-06-30 |
1994-01-06 |
Procter & Gamble Pharmaceuticals, Inc. |
Use of phosphonates for the treatment of osteoporosis
|
US5409911A
(en)
*
|
1992-09-11 |
1995-04-25 |
Merck & Co., Inc. |
Prostaglandin analog for treating osteoporosis
|
US5366965A
(en)
*
|
1993-01-29 |
1994-11-22 |
Boehringer Mannheim Gmbh |
Regimen for treatment or prophylaxis of osteoporosis
|
US5449819A
(en)
*
|
1994-06-06 |
1995-09-12 |
Merck & Co., Inc. |
Process for removing waste pox, alendronate and its by products
|
FR2727629A1
(fr)
*
|
1994-12-06 |
1996-06-07 |
Sanofi Sa |
Trousse pour cycle de traitement de l'osteoporose
|
CN1181012A
(zh)
*
|
1995-02-17 |
1998-05-06 |
麦克公司 |
减小非椎骨骨折危险的方法
|
US20010051616A1
(en)
*
|
1995-02-17 |
2001-12-13 |
David B. Karpf |
Method of lessening the risk of vertebral fractures
|
WO1996039107A1
(en)
|
1995-06-06 |
1996-12-12 |
Merck & Co., Inc. |
Bisphosphonate cement composition to prevent aseptic loosening of orthopedic implant devices
|
US20010031244A1
(en)
*
|
1997-06-13 |
2001-10-18 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical aerosol composition
|
US5994329A
(en)
*
|
1997-07-22 |
1999-11-30 |
Merck & Co., Inc. |
Method for inhibiting bone resorption
|
US6432932B1
(en)
|
1997-07-22 |
2002-08-13 |
Merck & Co., Inc. |
Method for inhibiting bone resorption
|
IT1303672B1
(it)
*
|
1998-07-28 |
2001-02-23 |
Nicox Sa |
Sali nitrati di farmaci attivi nei disordini ossei
|
EP1123401A1
(en)
|
1998-10-22 |
2001-08-16 |
The General Hospital Corporation |
BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP)
|
US6121253A
(en)
*
|
1998-11-20 |
2000-09-19 |
Merck Frosst Canada & Co. |
Prostaglandin conjugates for treating or preventing bone disease
|
DE69939275D1
(de)
*
|
1998-12-31 |
2008-09-18 |
Gen Hospital Corp |
Peptide, bestehend aus zwei funktionellen PTH-Domänen, die durch ein Linkermolekül verknüpft sind, und Derivate davon
|
US7057012B1
(en)
*
|
1998-12-31 |
2006-06-06 |
The General Hospital Corporation |
PTH functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules
|
US7534605B2
(en)
*
|
1999-06-08 |
2009-05-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
|
US7022815B1
(en)
|
1999-09-29 |
2006-04-04 |
The General Hospital Corporation |
Polypeptide derivatives of parathyroid hormone (PTH)
|
AU7734800A
(en)
*
|
1999-09-29 |
2001-04-30 |
General Hospital Corporation, The |
Polypeptide derivatives of parathyroid hormone (pth)
|
ATE412670T1
(de)
|
1999-09-29 |
2008-11-15 |
Gen Hospital Corp |
Parathyroid hormon (pth) polypeptidderivate
|
FR2801218B1
(fr)
*
|
1999-11-23 |
2001-12-28 |
Hoechst Marion Roussel Inc |
Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
|
AU2580001A
(en)
|
1999-12-20 |
2001-07-03 |
Merck & Co., Inc. |
Blister package for pharmaceutical treatment card
|
US6677320B2
(en)
|
2000-01-20 |
2004-01-13 |
Hoffmann-La Roches Inc. |
Parenteral bisphosphonate composition with improved local tolerance
|
ATE304856T1
(de)
*
|
2000-06-20 |
2005-10-15 |
Novartis Pharma Gmbh |
Methode zur verabreichung von biphosphonaten
|
US6833357B2
(en)
*
|
2000-06-20 |
2004-12-21 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for modulating muscle cell and tissue contractility
|
US20050147602A1
(en)
*
|
2000-10-19 |
2005-07-07 |
Maine Medical Center Research Institute |
Compositions, methods and kits relating to CTHRC1, a novel modulator of collagen matrix
|
US6630325B1
(en)
*
|
2000-10-19 |
2003-10-07 |
Maine Medical Center Research Institute |
Compositions, methods and kits relating to remodel
|
CA2454275C
(en)
*
|
2001-07-23 |
2012-10-23 |
The General Hospital Corporation |
Conformationally constrained parathyroid hormone (pth) analogs
|
US20030119771A1
(en)
*
|
2001-08-22 |
2003-06-26 |
Rompaey Luc Van |
Modulators of bone homeostasis identified in a high-throughput screen
|
US20030124118A1
(en)
*
|
2001-11-27 |
2003-07-03 |
Rasmus Rojkjaer |
Pharmaceutical composition comprising factor VII polypeptides and protein S inhibitors
|
US20080057059A1
(en)
*
|
2001-11-09 |
2008-03-06 |
Novo Nordisk Healthcare A/G |
Pharmaceutical Composition Comprising Factor VII Polypeptides and Protein S Inhibitors
|
US20050070504A1
(en)
*
|
2001-12-21 |
2005-03-31 |
The Procter & Gamble Co. |
Risedronate compositions and their methods of use
|
CN100479823C
(zh)
*
|
2001-12-21 |
2009-04-22 |
宝洁公司 |
双膦酸盐在制造药物套盒中的用途以及用于增加骨质的套盒
|
AU2002364051A1
(en)
*
|
2002-01-24 |
2003-09-02 |
Children's Medical Center Corporation |
Anti-cancer combination and use thereof
|
AU2003226148A1
(en)
*
|
2002-04-05 |
2003-10-27 |
Merck & Co., Inc. |
Method for inhibiting bone resorption with an alendronate and vitamin d formulation
|
ES2532393T3
(es)
*
|
2002-05-10 |
2015-03-26 |
F. Hoffmann-La Roche Ag |
Acidos bisfosfónicos para tratamiento y prevención de osteoporosis
|
EP1513523A1
(en)
*
|
2002-06-06 |
2005-03-16 |
Merck Frosst Canada & Co. |
1,5-disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases
|
FR2841472B1
(fr)
|
2002-06-28 |
2006-02-24 |
Agronomique Inst Nat Rech |
Composition nutritionnelle ou therapeutique contenant le compose hesperidine ou l'un de ses derives
|
US20050031610A1
(en)
*
|
2002-07-19 |
2005-02-10 |
Tae-Wan Kim |
CD44-related fragments, compositions and methods
|
US20040138180A1
(en)
*
|
2002-10-03 |
2004-07-15 |
Barr Laboratories, Inc. |
Bisphosphonate composition and process for the preparation thereof
|
BE1015150A3
(nl)
*
|
2002-10-21 |
2004-10-05 |
Sonitron Nv |
Verbeterde transducent
|
NZ536273A
(en)
*
|
2002-12-20 |
2007-08-31 |
Hoffmann La Roche |
High dose ibandronate formulation
|
EP1592434A4
(en)
*
|
2003-01-24 |
2009-07-01 |
Gen Hospital Corp |
PARATHORMONE ANALYSIS (PTH) WITH CONFORMATIONAL CONSTRAINTS WITH LACTAME BRIDGES
|
WO2004093902A1
(en)
*
|
2003-03-19 |
2004-11-04 |
The General Hospital Corporation |
CONFORMATIONALLY CONSTRAINED PARATHYROID HORMONES WITH α-HELIX STABILIZERS
|
FR2853549B1
(fr)
|
2003-04-11 |
2007-11-09 |
Agronomique Inst Nat Rech |
Composition nutritionnelle ou therapeutique contenant le compose oleuropeine ou l'un de ses derives
|
EP1653985A4
(en)
|
2003-07-17 |
2009-08-05 |
Gen Hospital Corp |
CONSTRAINTS CONTAINING CONTAINING HORMONE PARATHYROID (PTH) ANALOGUES
|
WO2005018640A1
(en)
*
|
2003-08-20 |
2005-03-03 |
The Procter & Gamble Company |
Kit for treatment of upper gastrointestinal tract conditions
|
CA2535359A1
(en)
|
2003-08-21 |
2005-03-03 |
Merck Frosst Canada Ltd. |
Cathepsin cysteine protease inhibitors
|
WO2005027921A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a bisphosphonate
|
US20050261250A1
(en)
*
|
2004-05-19 |
2005-11-24 |
Merck & Co., Inc., |
Compositions and methods for inhibiting bone resorption
|
ATE475412T1
(de)
|
2004-05-24 |
2010-08-15 |
Warner Chilcott Co Llc |
Enterische feste orale dosierform eines bisphosphonats mit einem chelate
|
UA87854C2
(xx)
|
2004-06-07 |
2009-08-25 |
Мерк Энд Ко., Инк. |
N-(2-бензил)-2-фенілбутанаміди як модулятори рецептора андрогену$n-(2-бензил)-2-фенилбутанамиды как модуляторы рецептора андрогена
|
PL1855674T3
(pl)
|
2005-03-02 |
2015-01-30 |
Merck Sharp & Dohme |
Kompozycja do hamowania katepsyny K
|
US8158153B2
(en)
*
|
2005-03-17 |
2012-04-17 |
Alkermes Pharma Ireland Limited |
Nanoparticulate bisphosphonate compositions
|
WO2007086914A2
(en)
*
|
2005-05-10 |
2007-08-02 |
Elan Pharma International, Limited |
Nanoparticulate clopidogrel formulations
|
CA2610803C
(en)
*
|
2005-06-02 |
2014-08-05 |
U.S. Borax Inc. |
Prevention and treatment of osteochondrosis in animals and humans
|
US20080293677A1
(en)
*
|
2005-06-06 |
2008-11-27 |
Brookler Kenneth H |
Use of Alternating Amine and Non-Amine Bisphosphonate Combinations For Treating Osteoporosis
|
JP2009545320A
(ja)
*
|
2006-08-04 |
2009-12-24 |
ザ ジェネラル ホスピタル コーポレイション |
副甲状腺ホルモン(pth)のポリペプチド誘導体
|
US7781418B2
(en)
|
2006-12-14 |
2010-08-24 |
Isis Innovation Ltd. |
Composition for treating bone disorders
|
KR101661730B1
(ko)
|
2007-08-01 |
2016-10-04 |
더 제너럴 하스피탈 코포레이션 |
G―단백질 결합 수용체를 이용한 스크리닝 방법 및 관련 조성물
|
PL2222636T3
(pl)
|
2007-12-21 |
2014-04-30 |
Ligand Pharm Inc |
Selektywne modulatory receptorów androgenowych (SARM) i ich zastosowania
|
US20100068211A1
(en)
*
|
2008-02-08 |
2010-03-18 |
Bateman Ted A |
Use of antiresorptive compounds to prevent ionizing radiation-induced activation of osteoclasts and resulting bone loss
|
WO2010143193A1
(en)
|
2009-06-11 |
2010-12-16 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Targeted liposomes comprising n-containing bisphosphonates and uses thereof
|
US8882740B2
(en)
*
|
2009-12-23 |
2014-11-11 |
Stryker Trauma Gmbh |
Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone
|
WO2011143406A2
(en)
|
2010-05-13 |
2011-11-17 |
The General Hospital Corporation |
Parathyroid hormone analogs and uses thereof
|
CN102372773B
(zh)
*
|
2010-08-11 |
2013-06-05 |
中国科学院生物物理研究所 |
人膀胱癌肿瘤标志物及其抗体和应用
|
WO2012112363A1
(en)
|
2011-02-14 |
2012-08-23 |
Merck Sharp & Dohme Corp. |
Cathepsin cysteine protease inhibitors
|
EP2716297B1
(en)
*
|
2011-03-11 |
2017-09-27 |
Tokyo University of Science Foundation |
D-glu-fniii14 polypeptide for use in treating cancer
|
EP2731591B1
(en)
|
2011-07-13 |
2020-06-17 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Liposomes co-encapsulating a bisphosphonate and an amphipathic agent
|
FR3005419B1
(fr)
|
2013-05-13 |
2015-09-04 |
Agronomique Inst Nat Rech |
Utilisation d'une association de deux composes pour le traitement et/ou la prevention de troubles osseux
|
WO2015051479A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Cathepsin cysteine protease inhibitors
|
AU2014332250B2
(en)
|
2013-10-08 |
2018-07-19 |
Merck Sharp & Dohme Corp. |
Cathepsin cysteine protease inhibitors
|
WO2015120580A1
(en)
|
2014-02-11 |
2015-08-20 |
Merck Sharp & Dohme Corp. |
Cathepsin cysteine protease inhibitors
|
PL407922A1
(pl)
|
2014-04-16 |
2015-10-26 |
Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością |
Nowe bisfosfoniany i ich zastosowanie
|
EP3148587B1
(en)
|
2014-05-30 |
2021-02-24 |
Pfizer Inc |
Carbonitrile derivatives as selective androgen receptor modulators
|
CA2951984C
(en)
|
2014-07-15 |
2023-10-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Isolated polypeptides of cd44 and uses thereof
|
FR3066919B1
(fr)
|
2017-06-06 |
2019-08-02 |
Institut National De La Recherche Agronomique (Inra) |
Composition de phycocyanine pour son utilisation pour inhiber la resorption osseuse.
|
WO2023275715A1
(en)
|
2021-06-30 |
2023-01-05 |
Pfizer Inc. |
Metabolites of selective androgen receptor modulators
|